CN107259635A - A kind of nicotine complex salt buccal tablets and preparation method thereof - Google Patents

A kind of nicotine complex salt buccal tablets and preparation method thereof Download PDF

Info

Publication number
CN107259635A
CN107259635A CN201710458893.8A CN201710458893A CN107259635A CN 107259635 A CN107259635 A CN 107259635A CN 201710458893 A CN201710458893 A CN 201710458893A CN 107259635 A CN107259635 A CN 107259635A
Authority
CN
China
Prior art keywords
complex salt
nicotine
buccal tablets
nicotine complex
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710458893.8A
Other languages
Chinese (zh)
Inventor
赵杨
段沅杏
杨继
田永峰
赵伟
杨柳
陈永宽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Tobacco Yunnan Industrial Co Ltd
Original Assignee
China Tobacco Yunnan Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Tobacco Yunnan Industrial Co Ltd filed Critical China Tobacco Yunnan Industrial Co Ltd
Priority to CN201710458893.8A priority Critical patent/CN107259635A/en
Publication of CN107259635A publication Critical patent/CN107259635A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of nicotine complex salt buccal tablets.Material composition includes 0.01~1 part of 30~70 parts of sweetener, 5~10 parts of nicotine complex salt, 0.5~10 part of adhesive, 0.5~5 part of acid-base modifier, 0.5~5 part of flavoring essence, 0.5~5 part of flavor enhancement, 0.1~5 part of lubricant and antioxidant.Product is obtained using direct compression method after raw material is well mixed.The present invention substitutes the tobacco powder composition in traditional buccal tablets with nicotine complex salt, and nicotine complex salt, which can uniformly mix, to be fitted in buccal tablets, reduces the grains of sand mouthfeel of product, allows consumer preferably to enjoy the physiology satisfaction that nicotine is brought.Nicotine continues slow release, improves the faster negative impression of consumer's nicotine release during edible buccal tablets, and reduce to oral cavity and the excitant of stomach.

Description

A kind of nicotine complex salt buccal tablets and preparation method thereof
Technical field
The invention belongs to smoke-free tobacco product technical field, be specifically related to it is a kind of using nicotine complex salt as mainly into Divide the buccal tablets prepared.Meanwhile, the invention further relates to the preparation method of described buccal tablets.
Background technology
Improved constantly recently as people's living standard, health and environmental consciousness are stepped up.Smoking is asked with health Topic is increasingly paid close attention to by masses.The material being detrimental to health in cigarette is largely produced from result of combustion of tobacco, makes non- What the flow measurement flue gas that the second-hand-cigarette of smoker's puzzlement is also due to cigarette burning generation was caused.Therefore, smoke-free tobacco product had been both The need for tobacco consumer being met, harm of the smoking to the public can be reduced again, and the research and development to such product seem even more important With it is urgent.
The species of smoke-free tobacco product mainly has buccal cigarette (not chewing, there is residue), gum base type chewing tobacco (to chew, there is residual Slag) and tobacco buccal tablets (not chewing, no residue).Buccal tablets has the characteristics of not producing second-hand-cigarette harm and hygienic environment-protecting, tool There are good market prospects.But traditional tobacco buccal tablets is tabletted after tobacco fine powder is mixed with other compositions, is being disappeared Exist during expense person's use coarse mouthfeel after buccal tablets dissolves in the oral cavity, free state nicotine release it is too fast, to oral cavity, throat And intestines and stomach stimulation it is larger the problems such as.
The content of the invention
In view of the above-mentioned deficiencies in the prior art, it is an object of the present invention to provide a kind of containing by main component of nicotine complex salt Change piece.
The present invention also aims to provide a kind of method for preparing the buccal tablets.
The purpose of the present invention is achieved by the following technical programs.
Unless otherwise indicated, percentage of the present invention is mass percent.
A kind of nicotine complex salt buccal tablets, is made up of the raw material of following weight parts:30~70 parts of sweetener, nicotine complex salt 5~10 parts, 0.5~10 part of adhesive, 0.5~5 part of acid-base modifier, 0.5~5 part of flavoring essence, 0.5~5 part of flavor enhancement, profit 0.01~1 part of 0.1~5 part of lubrication prescription and antioxidant.
Described sweetener is xylitol, D-sorbite, honey, fructose, sucrose, glucose, maltose, licorice powder, sweet tea One or more in sweet element, Aspartame, Sucralose, corn syrup.
Described nicotine complex salt is nicotine and malic acid, citric acid or salicylism reaction and obtained after freeze-dried White powder.
Described adhesive be sodium alginate, xanthans, sodium cellulose glycolate, carboxy-propyl cellulose, Arabic gum or One or more in maltodextrin.
Described acid-base modifier is sodium carbonate, sodium acid carbonate, potassium carbonate, saleratus, sodium citrate or potassium citrate In one or more.
Described flavor enhancement is the one or more in mint extract, Fragaia ananassa Duchesne extract or blueberry extract.
Described lubricant is the one or more in magnesium stearate, talcum powder or silica.
Described antioxidant is the one or more in Tea Polyphenols, sodium benzoate, sorbic acid or potassium sorbate.
The method for preparing the nicotine complex salt buccal tablets, comprises the following steps:
(1) each raw material for standby is weighed by weight:30~70 parts of sweetener, 5~10 parts of nicotine complex salt, adhesive 0.5 ~10 parts, 0.5~5 part of acid-base modifier, 0.5~5 part of flavoring essence, 0.5~5 part of flavor enhancement, 0.1~5 part of lubricant and anti- 0.01~1 part of oxidant;
(2) each raw material is well mixed, and control ph is 6~8, it is tabletted in tablet press machine;
(3) gained tabletting is dried 0.5 hour in an oven, it is 0.5~0.8% to control tabletting moisture, needed for producing Nicotine complex salt buccal tablets.
Relative to prior art, the present invention has advantages below:
1st, the tobacco powder composition in traditional buccal tablets is substituted with nicotine complex salt, nicotine complex salt, which can uniformly mix, matches somebody with somebody Into buccal tablets, the grains of sand mouthfeel of product is reduced.
2nd, nicotine complex salt has the effect for continuing slow release nicotine, improves consumer during edible buccal tablets The faster negative impression of nicotine release, and reduce to oral cavity and the excitant of stomach.
3rd, the buccal tablets based on nicotine complex salt can be directly buccal, and nicotine progressively discharges during edible, to consumer Bring physiology satisfaction;This process does not produce flue gas, can be used in various occasions.
Embodiment
The present invention is described in further detail by the following examples, but embodiment is not to the technology of the present invention side The restriction of case.It is all based on present invention teach that made change or equivalent substitution, all should belong to protection scope of the present invention.
Embodiment 1
Take 5g sodium alginates and 2g mint extracts to dissolve in deionized water, binder solution is made, then by 40g sweet teas Taste agent (5 parts of xylitols, 3 parts of glucose and 2 parts of Aspartames), 5g nicotine citrates, 2g flavoring essences, 2g magnesium stearates, 0.5g Tea Polyphenols is crossed after 100 mesh sieves and fully mixed with binder solution respectively, adds 0.5g sodium acid carbonates (acid-base modifier) Control ph is 6-8, is subsequently poured into tablet press machine, and tabletting is carried out according to every 1.0g specification.Tablet is dried 0.5 in an oven Hour, it is 0.5~0.8% to make pellet moisture control.Then packed, that is, obtain described nicotine complex salt buccal tablets.
Embodiment 2
Take 6g xanthans and 3g Fragaia ananassa Duchesne extracts to dissolve in deionized water, binder solution is made, then by 50g sweet tastes Agent (5 parts of D-sorbites and 5 portions of sucrose), 6g nicotine malate, 2g flavoring essences, 2g talcum powder, 0.5g sodium benzoates difference Cross after 100 mesh sieves and fully mixed with binder solution, add 0.5g saleratus (acid-base modifier) control ph for 6-8, Tablet press machine is subsequently poured into, tabletting is carried out according to every 1.0g specification.Tablet is dried 0.5 hour in an oven, makes particle water Sub-control is made as 0.5~0.8%.Then packed, that is, obtain described nicotine complex salt buccal tablets.
Embodiment 3
Take 7g Arabic gums and 5g blueberry extracts to dissolve in deionized water, binder solution is made, then by 60g sweet teas Taste agent (5 parts of xylitols, 3 parts of fructose and 2 parts of honey elements), 6g nicotine salicylate, 2g flavoring essences, 2g silica, 0.5g Potassium sorbate is crossed after 100 mesh sieves and fully mixed with binder solution respectively, adds 0.5g sodium acid carbonates (acid-base modifier) control PH value processed is 6-8, is subsequently poured into tablet press machine, and tabletting is carried out according to every 1.0g specification.Tablet is dried to 0.5 in an oven small When, it is 0.5~0.8% to make pellet moisture control.Then packed, that is, obtain described nicotine complex salt buccal tablets.

Claims (8)

1. a kind of nicotine complex salt buccal tablets, it is characterised in that be made up of the raw material of following weight parts:30~70 parts of sweetener, cigarette 5~10 parts of alkali complex salt, 0.5~10 part of adhesive, 0.5~5 part of acid-base modifier, 0.5~5 part of flavoring essence, flavor enhancement 0.5 ~5 parts, 0.01~1 part of 0.1~5 part of lubricant and antioxidant.
2. nicotine complex salt buccal tablets according to claim 1, it is characterised in that:Described sweetener is xylitol, mountain Pears sugar alcohol, honey, fructose, sucrose, glucose, maltose, licorice powder, honey element, Aspartame, Sucralose or corn syrup In one or more.
3. nicotine complex salt buccal tablets according to claim 1, it is characterised in that:Described nicotine complex salt be nicotine with Malic acid, citric acid or salicylism reaction and it is freeze-dried after obtained white powder.
4. nicotine complex salt buccal tablets according to claim 1, it is characterised in that:Described adhesive be sodium alginate, One or more in xanthans, sodium cellulose glycolate, carboxy-propyl cellulose, Arabic gum or maltodextrin.
5. nicotine complex salt buccal tablets according to claim 1, it is characterised in that:Described acid-base modifier is carbonic acid One or more in sodium, sodium acid carbonate, potassium carbonate, saleratus, sodium citrate or potassium citrate.
Described flavor enhancement is the one or more in mint extract, Fragaia ananassa Duchesne extract or blueberry extract.
6. nicotine complex salt buccal tablets according to claim 1, it is characterised in that:Described lubricant be magnesium stearate, One or more in talcum powder or silica.
7. nicotine complex salt buccal tablets according to claim 1, it is characterised in that:Described antioxidant be Tea Polyphenols, One or more in sodium benzoate, sorbic acid or potassium sorbate.
8. preparing the method for nicotine complex salt buccal tablets described in claim 1, comprise the following steps:
(1) each raw material for standby is weighed by weight:30~70 parts of sweetener, 5~10 parts of nicotine complex salt, adhesive 0.5~10 Part, 0.5~5 part of acid-base modifier, 0.5~5 part of flavoring essence, 0.5~5 part of flavor enhancement, 0.1~5 part of lubricant and anti-oxidant 0.01~1 part of agent;
(2) each raw material is well mixed, and control ph is 6~8, it is tabletted in tablet press machine;
(3) gained tabletting is dried 0.5 hour in an oven, it is 0.5~0.8% to control tabletting moisture, produces required nicotine Complex salt buccal tablets.
CN201710458893.8A 2017-06-16 2017-06-16 A kind of nicotine complex salt buccal tablets and preparation method thereof Pending CN107259635A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710458893.8A CN107259635A (en) 2017-06-16 2017-06-16 A kind of nicotine complex salt buccal tablets and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710458893.8A CN107259635A (en) 2017-06-16 2017-06-16 A kind of nicotine complex salt buccal tablets and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107259635A true CN107259635A (en) 2017-10-20

Family

ID=60066407

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710458893.8A Pending CN107259635A (en) 2017-06-16 2017-06-16 A kind of nicotine complex salt buccal tablets and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107259635A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2613211A (en) * 2022-04-01 2023-05-31 Amplicon Ab Alkaline oral formulations
WO2023187223A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Nicotine formulations
WO2023187224A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral formulations

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012134380A1 (en) * 2011-03-29 2012-10-04 Chill Of Sweden Ab Pouch containing nicotine in free salt form
CN105455190A (en) * 2016-02-01 2016-04-06 湖北中烟工业有限责任公司 Electronic cigarette liquid
CN105595404A (en) * 2015-10-20 2016-05-25 贵州中烟工业有限责任公司 Tobacco buccal tablet and preparation method thereof
CN105747267A (en) * 2014-12-17 2016-07-13 贵州中烟工业有限责任公司 Dissolvable smoke-free tobacco product and preparation method thereof
CN106456560A (en) * 2014-04-08 2017-02-22 费尔廷制药公司 Medical chewing gum

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012134380A1 (en) * 2011-03-29 2012-10-04 Chill Of Sweden Ab Pouch containing nicotine in free salt form
CN106456560A (en) * 2014-04-08 2017-02-22 费尔廷制药公司 Medical chewing gum
CN105747267A (en) * 2014-12-17 2016-07-13 贵州中烟工业有限责任公司 Dissolvable smoke-free tobacco product and preparation method thereof
CN105595404A (en) * 2015-10-20 2016-05-25 贵州中烟工业有限责任公司 Tobacco buccal tablet and preparation method thereof
CN105455190A (en) * 2016-02-01 2016-04-06 湖北中烟工业有限责任公司 Electronic cigarette liquid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2613211A (en) * 2022-04-01 2023-05-31 Amplicon Ab Alkaline oral formulations
WO2023187223A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Nicotine formulations
WO2023187224A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral formulations
GB2613211B (en) * 2022-04-01 2023-12-27 Amplicon Ab Alkaline oral formulations

Similar Documents

Publication Publication Date Title
US11723904B2 (en) Nicotine lozenge
US20230397647A1 (en) Chewable dissolvable nicotine tablet
US20230404131A1 (en) Dissolvable-chewable exhausted-tobacco tablet
CN105595404A (en) Tobacco buccal tablet and preparation method thereof
CN102499447B (en) Chinese style smoke-free tobacco product containing corsvenor momordica fruits
CN103284318B (en) Sublingual cigarette and preparation method thereof
US20150096574A1 (en) Dissolvable-chewable tobacco tablet
MX2011003882A (en) Smokeless dissolvable compressed tobacco product.
CN107259635A (en) A kind of nicotine complex salt buccal tablets and preparation method thereof
CN102894465A (en) Tobacco-containing areca catechu and preparation method thereof
CN103494323A (en) Smoke-free tobacco capable of reducing throat irritation and preparing method of smoke-free tobacco
CN102423121A (en) Bagged mouth-containing smokeless tobacco product with cocoa flavor
CN103478888B (en) A kind of quid of plum flavor
CN107334179A (en) A kind of gum base type chewing tobacco of the complex salt containing nicotine and preparation method thereof
CN101317620A (en) Chewing gum capable of relieving a craving for tobacco
CN116019249A (en) Buccal preparation for relieving fatigue and preparation method thereof
JP2924099B2 (en) Oral smoke suppressant
CA3214624A1 (en) Oral pouch product
EP4319572A1 (en) Encapsulated nicotine granules and methods of preparation thereof
CN104621327A (en) Cigarette-substituting chewing sugar and preparation method thereof
US20240189297A1 (en) Controlled-release nicotine chewing gum
US20220312822A1 (en) Encapsulated sweetener granules and methods of preparation thereof
US20220313678A1 (en) Spray dried nicotine for inclusion in oral products
US20220312826A1 (en) Liquid mixtures of triglyceride and liquid nicotine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20171020

WD01 Invention patent application deemed withdrawn after publication